Malignant Adrenal Gland Neoplasm — Trials

Malignant Adrenal Gland Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

99 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 16
Ph III recruiting: 0
Growth YoY: —
Industry share: 4%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05361083	First-in-human Evaluation of [18F]CETO	completed	Early Phase 1	20	Uppsala UniversityOTHER	1	May 4, 2022	clinicaltrials
NCT01086696	A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers	terminated	Early Phase 1	6	National Cancer Institute (NCI)NIH	1	Dec 17, 2019	clinicaltrials